Compare · DVA vs OTRK
DVA vs OTRK
Side-by-side comparison of DaVita Inc. (DVA) and Ontrak Inc. (OTRK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DVA and OTRK operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- DVA is the larger of the two at $12.33B, about 218.9x OTRK ($56.3M).
- Over the past year, DVA is up 39.4% and OTRK is down 78.9% - DVA leads by 118.3 points.
- DVA has hit the wire 12 times in the past 4 weeks while OTRK has been quiet.
- DVA has more recent analyst coverage (13 ratings vs 5 for OTRK).
- Company
- DaVita Inc.
- Ontrak Inc.
- Price
- $192.05-0.05%
- $0.32-13.05%
- Market cap
- $12.33B
- $56.3M
- 1M return
- -2.08%
- +2.94%
- 1Y return
- +39.45%
- -78.87%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 12
- 0
- Recent ratings
- 13
- 5
DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Ontrak Inc.
Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. The company's technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was founded in 2003 and is headquartered in Santa Monica, California.
Latest DVA
- DaVita Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Yale Phyllis R gifted 5,038 shares, decreasing direct ownership by 35% to 9,525 units (SEC Form 4)
- Director Pullin Dennis W was granted 250 shares, increasing direct ownership by 10% to 2,671 units (SEC Form 4)
- Director Schoppert Wendy Lee was granted 250 shares (SEC Form 4)
- Director Moore Gregory J. was granted 250 shares, increasing direct ownership by 3% to 7,813 units (SEC Form 4)
- Director Arway Pamela M was granted 250 shares, increasing direct ownership by 0.94% to 26,945 units (SEC Form 4)
- Director Yale Phyllis R was granted 250 shares, increasing direct ownership by 2% to 14,563 units (SEC Form 4)
- Director Hollar Jason M. was granted 250 shares, increasing direct ownership by 4% to 6,605 units (SEC Form 4)
- Director Desoer Barbara J was granted 250 shares (SEC Form 4)
- Director Schechter Adam H was granted 250 shares, increasing direct ownership by 5% to 5,692 units (SEC Form 4)
Latest OTRK
- Ontrak Inc. filed SEC Form 8-K: Other Events, Leadership Update
- SEC Form NT 10-Q filed by Ontrak Inc.
- Ontrak Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Ontrak Inc. filed SEC Form 8-K: Other Events, Leadership Update
- Electronic Data Interchange Market Size to Grow USD 74.36 billion by 2031, Rising Digital Transformation Across Various Industries Propels | The Insight Partners
- Ontrak Inc. filed SEC Form 8-K: Other Events
- Ontrak Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- Ontrak Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form 424B5 filed by Ontrak Inc.
- Ontrak Health Announces Pricing of $4 Million Public Offering